Table 3.
Localized Disease (n=15,978) HR (95% CI) |
p-value | Regional Disease (n=9,909) HR (95% CI) |
p-value | |
---|---|---|---|---|
Nodes Examined | ||||
1–3 | 1.25 (1.16, 1.35) | p= <.001 | 1.02 (0.94, 1.10) | p= 0.65 |
4–6 | 1.11 (1.03, 1.20) | p= 0.01 | 1.06 (0.99, 1.15) | p= 0.10 |
7–9 | 1.10 (1.00, 1.20) | p= 0.04 | 1.02 (0.94, 1.11) | p= 0.57 |
10 + | 1.0 | 1.0 | ||
% Nodes Positive | ||||
0.01–24% (n=2355) | 0.47 (0.43, 0.52) | p= <.001 | ||
25–49% (n=1231) | 0.67 (0.61, 0.74) | p= <.001 | ||
50–100% (n=1426) | 1.0 | |||
Age at Diagnosis (per year) | 1.02 (1.02, 1.03) | p= <.001 | 1.02 (1.01, 1.02) | p= <.001 |
Race | ||||
White | 1.0 | 1.0 | ||
Black | 1.21 (1.10, 1.34) | p= <.001 | 1.03 (0.92, 1.14) | p= 0.64 |
Other | 0.77 (0.68, 0.88) | p= <.001 | 0.96 (0.85, 1.07 | p= 0.45 |
Sex (Female vs. Male) | 0.77 (0.73, 0.82) | p= <.001 | 0.82 (0.77, 0.87) | p= <.001 |
Histologic Grade | ||||
Grade I | 1.0 | 1.0 | ||
Grade II | 1.37 (1.24, 1.51) | p= <.001 | 1.30 (1.16, 1.46) | p= <.001 |
Grade III | 1.72 (1.56, 1.89) | p= <.001 | 1.62 (1.44, 1.82) | p= <.001 |
Grade IV | 1.82 (1.58, 2.09) | p= <.001 | 1.57 (1.39, 1.79) | p= <.001 |
Tumor size (mm) | 1.00 (1.00, 1.00) | p= 0.009 | 1.00 (1.00, 1.01) | p= <.001 |
CI = Confidence Interval
HR = Hazard ratio